Harmony Biosciences Holdings Inc. — WAKIX (pitolisant) · cataplexy, pediatric patients 6 years of age and o.
Run-up into the decision (T-120 → T+5)
Daily close, T-120 (9/2/25) through T+5. Run-up high $40.51 on 12/18/25, low $25.9 on 10/24/25 (T-120 to T-1). FDA decision 2/17/26. Historical price action, not a forecast.